We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+11.56%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$8.44B
AUM Growth
+$1.09B
(+15%)
Cap. Flow
+$577M
Cap. Flow
% of AUM
6.84%
Top 10 Holdings %
Top 10 Hldgs %
15.63%
Holding
838
New
218
Increased
181
Reduced
162
Closed
220
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$123M |
| 2 |
HES
Hess
HES
|
+$115M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$108M |
| 4 |
Cencora
COR
|
+$106M |
| 5 |
Microsoft
MSFT
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$108M |
| 2 |
Analog Devices
ADI
|
+$105M |
| 3 |
Keysight
KEYS
|
+$101M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$82.2M |
| 5 |
Booking.com
BKNG
|
+$58.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.55% |
| 2 | Technology | 28% |
| 3 | Industrials | 9.43% |
| 4 | Energy | 7.74% |
| 5 | Consumer Discretionary | 5.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Advanced Drainage Systems
WMS
$11.1B
| $2.88M | 0.03% |
+25,293
| New | +$2.39M |
|
377
Avery Dennison
AVY
$13.2B
| $2.88M | 0.03% |
16,742
-27,791
| -62% | -$4.75M |
|
378
Wingstop
WING
$3.55B
| $2.87M | 0.03% |
14,342
-30,671
| -68% | -$5.99M |
|
379
Prothena Corp
PRTA
$436M
| $2.84M | 0.03% |
+41,633
| New | +$2.69M |
|
380
Walt Disney
DIS
$170B
| $2.83M | 0.03% |
31,751
-108,643
| -77% | -$10.3M |
|
|
DSM
381
BNY Mellon Strategic Municipal Bond Fund
DSM
$287M
| $2.81M | 0.03% |
492,946
-419,113
| -46% | -$2.4M |
|
382
CRISPR Therapeutics
CRSP
$4.88B
| $2.81M | 0.03% |
+50,000
| New | +$2.84M |
|
383
Arvinas
ARVN
$520M
| $2.79M | 0.03% |
+112,600
| New | +$2.9M |
|
384
Edgewise Therapeutics
EWTX
$4.13B
| $2.79M | 0.03% |
360,093
| – | – |
|
|
SGEN
385
PUT
DELISTED
Seagen Inc. Common Stock
SGEN
| $2.79M | 0.03% |
+14,500
| New | +$2.88M |
|
386
Insulet
PODD
$11.8B
| $2.79M | 0.03% |
+9,677
| New | +$2.94M |
|
387
Akamai
AKAM
$17.1B
| $2.77M | 0.03% |
30,818
-5,095
| -14% | -$436K |
|
|
RVNC
388
DELISTED
Revance Therapeutics, Inc.
RVNC
| $2.72M | 0.03% |
+107,580
| New | +$3.35M |
|
389
PepsiCo
PEP
$191B
| $2.7M | 0.03% |
+14,573
| New | +$2.72M |
|
|
MIO
390
DELISTED
Pioneer Municipal High Income Opportunities Fund
MIO
| $2.69M | 0.03% |
250,338
-19,570
| -7% | -$207K |
|
|
AMRN
391
Amarin Corp
AMRN
$297M
| $2.68M | 0.03% |
112,500
+12,500
| +13% | +$321K |
|
392
BJ's Restaurants
BJRI
$1.45B
| $2.64M | 0.03% |
82,997
+71,484
| +621% | +$2.18M |
|
|
MBSC
393
DELISTED
M3-Brigade Acquisition III Corp.
MBSC
| $2.61M | 0.03% |
249,998
| – | – |
|
394
Core & Main
CNM
$8.56B
| $2.6M | 0.03% |
+82,900
| New | +$2.22M |
|
|
OTLY
395
Oatly Group
OTLY
$468M
| $2.59M | 0.03% |
63,250
-68,384
| -52% | -$2.8M |
|
|
BLUE
396
DELISTED
bluebird bio
BLUE
| $2.58M | 0.03% |
39,145
-251
| -0.6% | -$18.4K |
|
397
Perrigo
PRGO
$1.48B
| $2.57M | 0.03% |
75,819
-75,820
| -50% | -$2.63M |
|
398
MoonLake Immunotherapeutics
MLTX
$1.48B
| $2.52M | 0.03% |
+49,479
| New | +$1.33M |
|
399
Pulmonx
LUNG
$89.5M
| $2.52M | 0.03% |
192,173
-577,913
| -75% | -$7.07M |
|
|
DAWN
400
DELISTED
Day One Biopharmaceuticals
DAWN
| $2.52M | 0.03% |
211,000
+59,972
| +40% | +$783K |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q2 2023 Portfolio in Review
As of Q2 2023, Woodline Partners held 838 positions worth $8.44B, up 15% from $7.35B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Woodline Partners deployed $577M of net new capital in Q2 2023, opening 218 new positions and adding to 181 existing holdings. Its largest new stake was Hess: 837,083 shares worth $114M.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 35% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Keysight, an estimated $101M trimmed.
- Woodline Partners's largest Q2 2023 buy was Hess: 837,083 shares worth $114M.
- Woodline Partners added most to Johnson & Johnson in Q2 2023, an estimated $123M increase.
- Woodline Partners's biggest Q2 2023 reduction was Keysight, cutting an estimated $101M.
- Woodline Partners fully exited Baxter International in Q2 2023, selling an estimated $108M.
- Woodline Partners's ten largest holdings make up 16% of its $8.44B portfolio in Q2 2023.
- Woodline Partners opened 218 new positions and closed 220 in Q2 2023.
- Woodline Partners's portfolio value rose 15% quarter-over-quarter to $8.44B.
Based on Woodline Partners's 13F filing for Q2 2023, filed 14 Aug 2023.